Fruchart, J. Et Al. 2019. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?. Diabetes Metabolic Syndrome: Clinical Research Reviews , vol.13, no.4 , 2723-2725.

Fruchart, J., Santos, R. D., Yamashita, S., Libby, P., Fruchart, J., Santos, R. D., ... Yamashita, S.(2019). Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?. Diabetes Metabolic Syndrome: Clinical Research Reviews , vol.13, no.4, 2723-2725.

Fruchart, Jean-Charles Et Al. "Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?," Diabetes Metabolic Syndrome: Clinical Research Reviews , vol.13, no.4, 2723-2725, 2019

Fruchart, Jean-Charles Et Al. "Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?." Diabetes Metabolic Syndrome: Clinical Research Reviews , vol.13, no.4, pp.2723-2725, 2019

Fruchart, J. Et Al. (2019) . "Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?." Diabetes Metabolic Syndrome: Clinical Research Reviews , vol.13, no.4, pp.2723-2725.

@article{article, author={Jean-Charles Fruchart Et Al. }, title={Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?}, journal={Diabetes Metabolic Syndrome: Clinical Research Reviews}, year=2019, pages={2723-2725} }